Tan Lee Su-Leng bought BGLC
August 13, 2026 · Form 4 insider transaction
Tan Lee Su-Leng bought 338,709 shares of BioNexus Gene Lab Corp., a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
338,709
Price
N/A
Total value
N/A
InsiderTan Lee Su-Leng
Role—
SecurityCommon Shares
Transaction codeA: Grant or award
Transaction dateAugust 13, 2026
Filing dateAugust 14, 2026
Shares owned after338,709
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents a fully vested Other Stock-Based Award of 338,709 shares of common stock, no par value, granted on August 13, 2026 under the BioNexus Gene Lab Corp. 2025 Equity Incentive Plan. The award was granted for completed services, for no cash consideration and valued for Plan purposes at $1.55 per share (the Nasdaq closing price on August 12, 2026).